• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-abl酪氨酸激酶受其可变N端氨基酸的负调控。

Negative regulation of c-abl tyrosine kinase by its variable N-terminal amino acids.

作者信息

Wang J Y

机构信息

Department of Biology, University of California, San Diego, La Jolla, 92093.

出版信息

Oncogene Res. 1988;3(3):293-8.

PMID:3144698
Abstract

Activation of the oncogenic potential of c-abl proto-oncogene has been correlated with the activation of its tyrosine kinase activity. The oncogenes derived from c-abl, e.g., gag/v-abl in Abelson murine leukemia virus or bcr/abl in chronic myelogenous leukemia, lack N-terminal coding sequences of the normal c-abl gene. In mouse and human cells, two sets of N-terminal amino acids encoded by 5'-variable exons are found in c-abl proteins. To assess the importance of N-terminal deletion in the activation of c-abl tyrosine kinase, a full length or an N-terminal deleted c-abl protein was expressed in bacteria and in monkey COS cells. Measurements of the autokinase activity of these two c-abl proteins showed that deletion of the N-terminal amino acids led to a three to five fold increase of the c-abl tyrosine kinase activity. Thus, the N-terminal deletion is important in the activation of c-abl proto-oncogene.

摘要

c-abl原癌基因致癌潜能的激活与其酪氨酸激酶活性的激活相关。源自c-abl的癌基因,例如艾贝尔森鼠白血病病毒中的gag/v-abl或慢性粒细胞白血病中的bcr/abl,缺乏正常c-abl基因的N端编码序列。在小鼠和人类细胞中,c-abl蛋白中发现了由5'-可变外显子编码的两组N端氨基酸。为了评估N端缺失在c-abl酪氨酸激酶激活中的重要性,在细菌和猴COS细胞中表达了全长或N端缺失的c-abl蛋白。对这两种c-abl蛋白的自身激酶活性的测量表明,N端氨基酸的缺失导致c-abl酪氨酸激酶活性增加了三到五倍。因此,N端缺失在c-abl原癌基因的激活中很重要。

相似文献

1
Negative regulation of c-abl tyrosine kinase by its variable N-terminal amino acids.c-abl酪氨酸激酶受其可变N端氨基酸的负调控。
Oncogene Res. 1988;3(3):293-8.
2
Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential.c-abl酪氨酸激酶N端调控结构域的缺失激活了其致癌潜能。
EMBO J. 1989 Jan;8(1):137-47. doi: 10.1002/j.1460-2075.1989.tb03358.x.
3
Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.嵌合Gag-Arg/Abl分子的分析表明,Arg C末端结构域具有独特的负调控作用。
Oncogene. 1996 Feb 1;12(3):631-40.
4
Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.小鼠c-abl原癌基因的激活:一个点突变对致癌激活的影响。
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6502-6. doi: 10.1073/pnas.87.17.6502.
5
A chimeric receptor/oncogene that can be regulated by a ligand in vitro and in vivo.一种在体外和体内均可由配体调控的嵌合受体/癌基因。
J Clin Invest. 1997 Oct 1;100(7):1708-15. doi: 10.1172/JCI119695.
6
Tyrosine phosphorylation and activation of focal adhesion kinase (p125FAK) by BCR-ABL oncoprotein.BCR-ABL癌蛋白导致的粘着斑激酶(p125FAK)的酪氨酸磷酸化及激活
Exp Hematol. 1995 Oct;23(11):1153-9.
7
Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.
Science. 1990 Mar 2;247(4946):1079-82. doi: 10.1126/science.2408149.
8
Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.Bcr与Abl的相互作用:通过隔离Bcr实现c-Abl的致癌激活。
Cancer Res. 2003 Jan 15;63(2):298-303.
9
Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.致癌病毒酪氨酸蛋白激酶的大多数底物在正常细胞中可被细胞酪氨酸蛋白激酶磷酸化。
Oncogene Res. 1988 Sep;3(2):105-15.
10
Bcr: a negative regulator of the Bcr-Abl oncoprotein in leukemia.Bcr:白血病中Bcr-Abl癌蛋白的负调节因子。
Oncogene. 2002 Dec 9;21(56):8560-7. doi: 10.1038/sj.onc.1206083.

引用本文的文献

1
Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin pedestals.肠致病性大肠杆菌利用冗余酪氨酸激酶形成肌动蛋白基座。
Mol Biol Cell. 2004 Aug;15(8):3520-9. doi: 10.1091/mbc.e04-02-0093. Epub 2004 May 21.
2
An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias.肌动蛋白结合功能有助于费城染色体阳性人类白血病的Bcr-Abl癌蛋白介导的细胞转化。
EMBO J. 1993 Apr;12(4):1533-46. doi: 10.1002/j.1460-2075.1993.tb05797.x.
3
Hormone-conditional transformation by fusion proteins of c-Abl and its transforming variants.
通过c-Abl及其转化变体的融合蛋白进行激素条件性转化
EMBO J. 1993 Jul;12(7):2809-19. doi: 10.1002/j.1460-2075.1993.tb05942.x.
4
Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential.c-abl酪氨酸激酶N端调控结构域的缺失激活了其致癌潜能。
EMBO J. 1989 Jan;8(1):137-47. doi: 10.1002/j.1460-2075.1989.tb03358.x.
5
Conservation of function of Drosophila melanogaster abl and murine v-abl proteins in transformation of mammalian cells.黑腹果蝇abl蛋白和鼠类v-abl蛋白在哺乳动物细胞转化中的功能保守性。
J Virol. 1990 May;64(5):2226-35. doi: 10.1128/JVI.64.5.2226-2235.1990.
6
Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor.细胞内抑制剂对人ABL酪氨酸激酶调控的证据。
Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5927-31. doi: 10.1073/pnas.88.13.5927.
7
Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins.bcr/abl融合蛋白中的bcr序列激活酪氨酸激酶以及c-abl的微丝结合功能。
Mol Cell Biol. 1991 Mar;11(3):1553-65. doi: 10.1128/mcb.11.3.1553-1565.1991.